Mycobacterial Infections Collection
 21-40 of 397 Articles
Ideas and Opinions |  21 June 2005
Independent Medical Examinations: An Expanding Source of Physician Liability
Ken Baum, MD, JD
Ann Intern Med. 2005;142(12_Part_1):974-978. doi:10.7326/0003-4819-142-12_Part_1-200506210-00007
Improving Patient Care |  1 March 2005 FREE
Fumbled Handoffs: One Dropped Ball after Another
Tejal K. Gandhi, MD, MPH
Ann Intern Med. 2005;142(5):352-358. doi:10.7326/0003-4819-142-5-200503010-00010
Brief Communications |  4 May 2004
Early Diagnosis of Subclinical Multidrug-Resistant Tuberculosis
Luca Richeldi, MD, PhD; Katie Ewer, BSc; Monica Losi, BSc; et al.
Ann Intern Med. 2004;140(9):709-713. doi:10.7326/0003-4819-140-9-200405040-00010
Brief Communications |  5 November 2002
Successful Discontinuation of Therapy for Disseminated Mycobacterium avium Complex Infection after Effective Antiretroviral Therapy
Stephen D. Shafran, MD; Laura D. Mashinter, BScN, RN; Peter Phillips, MD; et al.
Ann Intern Med. 2002;137(9):734-737. doi:10.7326/0003-4819-137-9-200211050-00008
Articles |  15 October 2002
Short-Course Rifampin and Pyrazinamide Compared with Isoniazid for Latent Tuberculosis Infection: A Multicenter Clinical Trial
Robert M. Jasmer, MD; Jussi J. Saukkonen, MD; Henry M. Blumberg, MD; et al.
Ann Intern Med. 2002;137(8):640-647. doi:10.7326/0003-4819-137-8-200210150-00007
Current Clinical Issues |  21 August 2001
The Cochrane Collaboration
Aaron Levin
Ann Intern Med. 2001;135(4):309-312. doi:10.7326/0003-4819-135-4-200108210-00035
Current Clinical Issues |  16 January 2001
Reporting Standards and the Transparency of Trials
Aaron Levin
Ann Intern Med. 2001;134(2):169-172. doi:10.7326/0003-4819-134-2-200101160-00025
Articles |  21 November 2000
Hospital Ventilation and Risk for Tuberculous Infection in Canadian Health Care Workers
Dick Menzies, MD, MSc; Anne Fanning, MD; Lilian Yuan, MD; et al.
Ann Intern Med. 2000;133(10):779-789. doi:10.7326/0003-4819-133-10-200011210-00010
Articles |  19 October 1999
Transmission of Tuberculosis in a Jail
Timothy F. Jones, MD; Allen S. Craig, MD; Sarah E. Valway, DMD, MPH; et al.
Ann Intern Med. 1999;131(8):557-563. doi:10.7326/0003-4819-131-8-199910190-00002
Editorials |  19 October 1999
On Target: A Tuberculosis Control Strategy Whose Time Has Come
Lee B. Reichman, MD, MPH
Ann Intern Med. 1999;131(8):617-618. doi:10.7326/0003-4819-131-8-199910190-00011
Brief Communications |  6 July 1999
Persistence and Boosting of Bacille Calmette-Guérin–Induced Delayed-Type Hypersensitivity
Daniel F. Hoft, MD, PhD; Jan M. Tennant, RN
Ann Intern Med. 1999;131(1):32-36. doi:10.7326/0003-4819-131-1-199907060-00007
Articles |  15 June 1999
A Molecular Epidemiologic Analysis of Tuberculosis Trends in San Francisco, 1991–1997
Robert M. Jasmer, MD; Judith A. Hahn, MA; Peter M. Small, MD; et al.
Ann Intern Med. 1999;130(12):971-978. doi:10.7326/0003-4819-130-12-199906150-00004
Articles |  2 March 1999
Delays in the Suspicion and Treatment of Tuberculosis among Hospitalized Patients
Venkatarama K. Rao, MD, PhD; Elizabeth P. Iademarco, RN, MPH; Victoria J. Fraser, MD; et al.
Ann Intern Med. 1999;130(5):404-411. doi:10.7326/0003-4819-130-5-199903020-00004
Articles |  1 December 1998
Use of DNA Fingerprinting To Assess Tuberculosis Infection Control
Audrey L. French, MD; Sharon F. Welbel, MD; Stephen E. Dietrich, MS; et al.
Ann Intern Med. 1998;129(11_Part_1):856-861. doi:10.7326/0003-4819-129-11_Part_1-199812010-00003
Academia and the Profession |  1 June 1998
At Swim-Two-Birds
Flann O'Brien
Ann Intern Med. 1998;128(11):921. doi:10.7326/0003-4819-128-11-199806010-00011
Articles |  15 December 1997
Monitored Isoniazid Prophylaxis for Low-Risk Tuberculin Reactors Older Than 35 Years of Age: A Risk-Benefit and Cost-Effectiveness Analysis
Shelley R. Salpeter, MD; Gillian D. Sanders, AB; Edwin E. Salpeter, PhD; et al.
Ann Intern Med. 1997;127(12):1051-1061. doi:10.7326/0003-4819-127-12-199712150-00001
Currents |  15 November 1997
Preparing for Thalidomide's Comeback
Cori Vanchieri
Ann Intern Med. 1997;127(10):951-952. doi:10.7326/0003-4819-127-10-199711150-00023
Editorials |  1 September 1997
Vaccines for Tuberculosis: The Glass Remains Half Empty
Jeffrey Glassroth, MD
Ann Intern Med. 1997;127(5):403-404. doi:10.7326/0003-4819-127-5-199709010-00012
Brief Communications |  15 August 1997
Reduced Plasma Concentrations of Antituberculosis Drugs in Patients with HIV Infection
Jan Sahai, PharmD; Keith Gallicano, PhD; Lori Swick, BSc; et al.
Ann Intern Med. 1997;127(4):289-293. doi:10.7326/0003-4819-127-4-199708150-00006
Brief Communications |  1 July 1997
A Nosocomial Outbreak of Multidrug-Resistant Tuberculosis
Thomas A. Kenyon, MD, MPH; Renee Ridzon, MD; Roberta Luskin-Hawk, MD; et al.
Ann Intern Med. 1997;127(1):32-36. doi:10.7326/0003-4819-127-1-199707010-00006
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.